drugset / Trial / NCT04599894
Reducing Postoperative Side Effect of Pregabalin
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study was to determine 1) if pregabalin, when given 37.5 mg twice on the day before surgery, would be effective in reducing the early postoperative side effects including dizziness, nausea, vomiting and sedation of receiving pregabalin 75mg two hours pre-operatively and 75mg per day until the third postoperative day; and 2) whether this intervention affected the opioids consumption, and independent transfers at six hours post-op, time to readiness for independent transfers, time to readiness for discharge and pain or not.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2021-04-30
- Completion
- 2021-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 75 mg | Oral |